to terminate addiction to legal and illegal drugs.
Lightlake Therapeutics Inc (LLTP OTCBB) has acquired US Patent 5,587,381, entitled: ‘Method for terminating methadone maintenance through extinction of the opiate-taking responses’, using an opioid antagonist as treatment. The Patent also covers treatment for addiction to other legally available opioids and to stimulant drugs such as Cocaine and Amphetamines.

Unmet Need

Opiate addiction is a major worldwide health problem.  Traditional treatments attempt to increase the addict's will power to withstand the craving for opiates but do not decrease the craving itself. For a large percentage of addicts this is not sufficient: eventually they give in to the craving and resume using the drugs.

In the USA alone there are more than 2 million adults abusing prescription pain killers such as Oxycontin and Vicodin, 5 million people taking cocaine regularly, 700,000 regular amphetamine users and thousands of methadone or...